Literature DB >> 3943792

Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage.

A L Boks, E J Brommer, S W Schalm, H H Van Vliet.   

Abstract

In a study of severe, decompensated liver failure, we tried to find a correlation between hemorrhage and parameters of hemostasis and fibrinolysis. Three groups of patients were studied: alcoholic cirrhosis; nonalcoholic cirrhosis, and acute liver failure without known prior liver disease. The two cirrhotic groups did not differ significantly from each other in coagulation or in fibrinolytic parameters, although liver function was more impaired in nonalcoholic cirrhosis. The levels of clotting factors, antithrombin III, prekallikrein, plasminogen and alpha 2-antiplasmin were significantly lower in the third group. Mean values of fibrinolytic activity (fibrin plate method) were slightly reduced as compared to normal in all three groups. Tissue plasminogen activator-related antigen tended to be elevated especially in alcoholic cirrhosis. The free fast-acting plasminogen activator inhibitor showed extremely high and extremely low levels in some patients among all three groups. Nonvariceal, capillary-type bleeding, including mucosal bleeding, hematomas and bleeding from puncture sites correlated with low thrombotest and normotest levels (p less than 0.01), low fibrinogen concentration (p less than 0.05) and with a high quotient of fibrinolytic activity (square root of lysis area) and normotest (p less than 0.001). The ratio between fibrin formation and dissolution appears to be an important parameter of hemorrhagic tendency in liver disease. Variceal bleeding appeared not to be related to impairment of hemostasis or fibrinolysis.

Entities:  

Mesh:

Year:  1986        PMID: 3943792     DOI: 10.1002/hep.1840060115

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

1.  Massive blood transfusion after the first cut in liver transplantation predicts renal outcome and survival.

Authors:  Benedikt Reichert; Alexander Kaltenborn; Thomas Becker; Mario Schiffer; Jürgen Klempnauer; Harald Schrem
Journal:  Langenbecks Arch Surg       Date:  2014-03-30       Impact factor: 3.445

2.  Severe prolongation of the INR in spur cell anemia of cirrhosis: true-true and related?

Authors:  Vinay Sundaram; Abdullah M S Al-Osaimi; Jason J Lewis; Ton Lisman; Stephen H Caldwell
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

3.  Hyperfibrinolysis in hepatosplenic schistosomiasis.

Authors:  N E el-Bassiouni; A E el Bassiouny; H R el-Khayat; M M Akl; S A Omran
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

4.  The Natural History of Severe Acute Liver Injury.

Authors:  David G Koch; J L Speiser; V Durkalski; R J Fontana; T Davern; B McGuire; R T Stravitz; A M Larson; I Liou; O Fix; M L Schilsky; T McCashland; J E Hay; N Murray; O S Shaikh; D Ganger; A Zaman; S B Han; R T Chung; R S Brown; S Munoz; K R Reddy; L Rossaro; R Satyanarayana; A J Hanje; J Olson; R M Subramanian; C Karvellas; B Hameed; A H Sherker; W M Lee; A Reuben
Journal:  Am J Gastroenterol       Date:  2017-04-25       Impact factor: 10.864

5.  Coagulopathy in cirrhosis: A prospective study to correlate conventional tests of coagulation and bleeding following invasive procedures in cirrhotics.

Authors:  Apurva Shah; Deepak Amarapurkar; Mrudul Dharod; Madhuri Chandnani; Rajiv Baijal; Praveen Kumar; Mayank Jain; Nikhil Patel; Praful Kamani; Sonali Gautam; Nimish Shah; Sandeep Kulkarni; Soham Doshi
Journal:  Indian J Gastroenterol       Date:  2015-09

Review 6.  Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis.

Authors:  Massimo Primignani; Giulia Tosetti; Vincenzo La Mura
Journal:  World J Hepatol       Date:  2015-12-18

Review 7.  Venous thromboembolism in cirrhosis.

Authors:  Zhineng J Yang; Karen A Costa; Enrico M Novelli; Roy E Smith
Journal:  Clin Appl Thromb Hemost       Date:  2012-10-17       Impact factor: 2.389

8.  Risks and predicting factors of bleeding complications in hepatitis B virus-related acute-on-chronic liver failure.

Authors:  Hong-Ying Guo; Zheng-Guo Zhang; Yu-Yi Zhang; Xue Mei; Yu Liu; Jie-Fei Wang; Zhi-Ping Qian; Wei Yuan
Journal:  Turk J Gastroenterol       Date:  2020-09       Impact factor: 1.852

9.  Plasma concentrations of endogenous heparinoids in portal hypertension.

Authors:  R F McKee; S Hodson; J Dawes; O J Garden; D C Carter
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

Review 10.  Management of acute liver failure.

Authors:  R Todd Stravitz; David J Kramer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08-04       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.